Cholesterol efflux capacity (CEC) is a measure of HDL function that， in cell-based studies， has demonstrated an inverse association with cardiovascular disease. The cell-based measure of CEC is complex and low-throughput. We hypothesized that assessment of the lipoprotein proteome would allow for precise， high-throughput CEC prediction.
Cholesterol efflux capacity (CEC) is a measure of HDL function that， in cell-based studies， has demonstrated an inverse association with cardiovascular disease. The cell-based measure of CEC is complex and low-throughput. We hypothesized that assessment of the lipoprotein proteome would allow for precise， high-throughput CEC prediction.
